For women with early-stage oestrogen receptor (ER)-positive breast cancer, adjuvant tamoxifen reduces 15-year breast cancer mortality by a third. Aromatase inhibitors are more effective than tamoxifen in postmenopausal women but are ineffective in premenopausal women when used without ovarian suppression. We aimed to investigate whether premenopausal women treated with ovarian suppression benefit from aromatase inhibitors.

Aromatase inhibitors versus tamoxifen in premenopausal women with oestrogen receptor-positive early-stage breast cancer treated with ovarian suppression: a patient-level meta-analysis of 7030 women from four randomised trials / Bradley, R.; Braybrooke, J.; Gray, R.; Hills, R. K.; Liu, Z.; Pan, H.; Peto, R.; Dodwell, D.; Mcgale, P.; Taylor, C.; Francis, P. A.; Gnant, M.; Perrone, F.; Regan, M. M.; Berry, R.; Boddington, C.; Clarke, M.; Davies, C.; Davies, L.; Duane, F.; Evans, V.; Gay, J.; Gettins, L.; Godwin, J.; James, S.; Liu, H.; Mackinnon, E.; Mannu, G.; Mchugh, T.; Morris, P.; Read, S.; Straiton, E.; Jakesz, R.; Fesl, C.; Pagani, O.; Gelber, R.; De Laurentiis, M.; De Placido, S.; Gallo, C.; Albain, K.; Anderson, S.; Arriagada, R.; Bartlett, J.; Bergsten-Nordstrom, E.; Bliss, J.; Brain, E.; Carey, L.; Coleman, R.; Cuzick, J.; Davidson, N.; Del Mastro, L.; Di Leo, A.; Dignam, J.; Dowsett, M.; Ejlertsen, B.; Goetz, M.; Goodwin, P.; Halpin-Murphy, P.; Hayes, D.; Hill, C.; Jagsi, R.; Janni, W.; Loibl, S.; Mamounas, E. P.; Martin, M.; Mukai, H.; Nekljudova, V.; Norton, L.; Ohashi, Y.; Pierce, L.; Poortmans, P.; Pritchard, K. I.; Raina, V.; Rea, D.; Robertson, J.; Rutgers, E.; Spanic, T.; Sparano, J.; Steger, G.; Tang, G.; Toi, M.; Tutt, A.; Viale, G.; Wang, X.; Whelan, T.; Wilcken, N.; Wolmark, N.; Cameron, D.; Bergh, J.; Swain, S. M.. - In: THE LANCET ONCOLOGY. - ISSN 1474-5488. - 23:3(2022), pp. 382-392. [10.1016/S1470-2045(21)00758-0]

Aromatase inhibitors versus tamoxifen in premenopausal women with oestrogen receptor-positive early-stage breast cancer treated with ovarian suppression: a patient-level meta-analysis of 7030 women from four randomised trials

De Laurentiis M.;De Placido S.;Davidson N.;Di Leo A.;Norton L.;
2022

Abstract

For women with early-stage oestrogen receptor (ER)-positive breast cancer, adjuvant tamoxifen reduces 15-year breast cancer mortality by a third. Aromatase inhibitors are more effective than tamoxifen in postmenopausal women but are ineffective in premenopausal women when used without ovarian suppression. We aimed to investigate whether premenopausal women treated with ovarian suppression benefit from aromatase inhibitors.
2022
Aromatase inhibitors versus tamoxifen in premenopausal women with oestrogen receptor-positive early-stage breast cancer treated with ovarian suppression: a patient-level meta-analysis of 7030 women from four randomised trials / Bradley, R.; Braybrooke, J.; Gray, R.; Hills, R. K.; Liu, Z.; Pan, H.; Peto, R.; Dodwell, D.; Mcgale, P.; Taylor, C.; Francis, P. A.; Gnant, M.; Perrone, F.; Regan, M. M.; Berry, R.; Boddington, C.; Clarke, M.; Davies, C.; Davies, L.; Duane, F.; Evans, V.; Gay, J.; Gettins, L.; Godwin, J.; James, S.; Liu, H.; Mackinnon, E.; Mannu, G.; Mchugh, T.; Morris, P.; Read, S.; Straiton, E.; Jakesz, R.; Fesl, C.; Pagani, O.; Gelber, R.; De Laurentiis, M.; De Placido, S.; Gallo, C.; Albain, K.; Anderson, S.; Arriagada, R.; Bartlett, J.; Bergsten-Nordstrom, E.; Bliss, J.; Brain, E.; Carey, L.; Coleman, R.; Cuzick, J.; Davidson, N.; Del Mastro, L.; Di Leo, A.; Dignam, J.; Dowsett, M.; Ejlertsen, B.; Goetz, M.; Goodwin, P.; Halpin-Murphy, P.; Hayes, D.; Hill, C.; Jagsi, R.; Janni, W.; Loibl, S.; Mamounas, E. P.; Martin, M.; Mukai, H.; Nekljudova, V.; Norton, L.; Ohashi, Y.; Pierce, L.; Poortmans, P.; Pritchard, K. I.; Raina, V.; Rea, D.; Robertson, J.; Rutgers, E.; Spanic, T.; Sparano, J.; Steger, G.; Tang, G.; Toi, M.; Tutt, A.; Viale, G.; Wang, X.; Whelan, T.; Wilcken, N.; Wolmark, N.; Cameron, D.; Bergh, J.; Swain, S. M.. - In: THE LANCET ONCOLOGY. - ISSN 1474-5488. - 23:3(2022), pp. 382-392. [10.1016/S1470-2045(21)00758-0]
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11588/890570
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 99
  • ???jsp.display-item.citation.isi??? 89
social impact